Skip to content
PeptideAgent

Compounding pharmacies in South Dakota

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The South Dakota Board of Pharmacy (South Dakota Department of Health) regulates compounding pharmacies in South Dakota. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

South Dakota at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving South Dakota

No verified compounding pharmacies serving South Dakota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in South Dakota

The South Dakota Board of Pharmacy licenses pharmacies and pharmacists under SDCL chapter 36-11 and regulates practice through Administrative Rules of South Dakota article 20:51, with compounding practices in chapter 20:51:31. SDCL 36-11-19.3 requires any nonresident pharmacy to be licensed before doing business in South Dakota, to be licensed and in good standing in its home state, and to submit its most recent home-state inspection report, so an out-of-state pharmacy shipping to South Dakota patients needs a South Dakota nonresident license. The compounding chapter was rewritten effective June 2, 2024, when the older sterile compounding rules (20:51:31:02 to 20:51:31:31) were repealed, and amended again effective September 15, 2025 (52 SDR 27): rule 20:51:31:32 now requires all sterile and nonsterile compounding to follow federal law and the February 1, 2024 USP chapters 797, 795, 800, and 825, and rules 20:51:31:33 and 20:51:31:34 require a compounding policy and procedure manual with a quality assurance program and USP physical, equipment, and environmental standards. South Dakota has not adopted its own list of compoundable bulk substances; the federal 503A test applies (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [4] [5]

Compounded GLP-1 access in South Dakota

South Dakota has not published a state rule that is looser than FDA policy. Because many South Dakota patients use mail order, confirming that the dispensing pharmacy holds a South Dakota nonresident license is the main practical check. [1] [2] [6]

Research use only sellers in South Dakota

SDCL chapter 36-11 reserves dispensing of prescription drugs to licensed pharmacies and pharmacists, so shipping "research use only" injectable peptides to South Dakota consumers is not a licensed pharmacy activity. [2] [7]

How to check a compounding pharmacy in South Dakota

  1. Search the South Dakota Board of Pharmacy (South Dakota Department of Health) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration South Dakota requires before it ships to you. [1] [2] [3] [4] [5]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Dakota. [2] [7]

Common questions in South Dakota

Does an out-of-state pharmacy need a South Dakota license to ship me compounded peptides?

Yes. SDCL 36-11-19.2 and 36-11-19.3 define nonresident pharmacies and require them to be licensed by the South Dakota Board of Pharmacy, with proof of good standing in their home state. Check the Board's license lookup before ordering. [1] [2] [3]

Which rules govern compounding in South Dakota?

Compounding is governed by SDCL chapter 36-11 and Administrative Rules of South Dakota chapter 20:51:31, which since September 15, 2025 requires compounding to follow federal law and the February 1, 2024 USP compounding chapters. South Dakota has no state bulks list, so a peptide must be an approved drug component, have a USP or NF monograph, or be on the FDA 503A bulks list. [2] [4] [5]

All peptide legal questions for South Dakota

Sources

  1. [1]South Dakota Board of Pharmacy (South Dakota Department of Health)
  2. [2]South Dakota Codified Laws chapter 36-11, Pharmacists and pharmacies (including nonresident pharmacy licensure, 36-11-19.2 and 36-11-19.3)
  3. [3]South Dakota Codified Laws 36-11-19.3, Nonresident pharmacy licensure
  4. [4]Administrative Rules of South Dakota chapter 20:51:31, Compounding practices (amended effective September 15, 2025)
  5. [5]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  6. [6]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  7. [7]21 U.S.C. 331, Prohibited acts